Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Covid-19 HSE Clinical Guidance and Evidence

* Phone users, please scroll down to view content. Queries to:


Interim Clinical Guidance

Management of Ongoing Medication: Interim Clinical Guidance
| COVID-19 Interim Clinical Guidance - VTE protocol and patient information for acute hospitals (CD19-120 / 21.04.20) (Link to Emergency Department/Wards)
| Anticipatory Prescribing in the Last Hours or Days of Life (CD19-008 001 / 06.04.20) (Link to Palliative care)
| HSE COVID-19: Interim Clinical Guidance – Anti-Inflammatory Medicines for Treatment of COVID-19 symptoms (CD19-094) (Download PDF)
| HSE COVID-19: Interim Clinical Guidance – Antihypertensive (High Blood Pressure) Medicines (CD19-093) (Download PDF)
| HSE COVID-19: Interim Clinical Guidance: Immunosuppressant Therapy (CD19-104 004 / 04.11.20) (Download PDF)
| COVID 19 Interim Clinical Guidance for Medicines Management for Isolation Units for People Who Use Drugs (CD19-155 / 28.04.20) (Download PDF)

Clinical management of COVID-19 in acute setting
| Interim Guidance for the Use of Antiviral Therapy in the Clinical Management of Acute Respiratory Infection with SARS-CoV-2 (COVID-19) (CD19-035 005 / 04.01.21) (Download PDF)
| Interim Guidance for the use of Tocilizumab in the management  of patients with severe COVID-19 (CD19-062 004 / 25.01.21) (Download PDF)
| HSE Interim Guidance for the use of Systemic Corticosteroids in the Management of Hospitalised Patients with Severe COVID-19 Disease (CD19-196 / 25.09.20) (Download PDF)

| COVID-19 Medication Safety Poster and Screensaver (Download PDF)
| Pharmacy Guidance (HPSC link)

Summaries of Evidence 

| Medication: Rapid Evidence Reviews and Summaries of Evidence

National Health Library & Knowledge Service. Health Service Executive. Dr. Steevens' Hospital, Dublin 8. Tel: 01-6352555/8. Email: